Table 5. Secondary efficacy parameters in the intent-to-treat population.

	Arm A	Arm B	Arm C	Arm D
	Months	Months	Months	Months
Duration of response and stabilisation	5.9 (0.8–12.7)	3.9 (1.0–13.0)	5.3 (1.3–8.9)	3.4 (1.3–6.9)
Time to progression	2.7 (1.0–12.8)	3.5 (0.0–13.2)	3.8 (0.0–8.9)	2.8 (0.0–7.0)
Time to treatment failure	2.7 (1.0–12.8)	2.3 (0.6–8.3)	3.2 (0.4–7.1)	1.7 (0.5–7.1)
Survival	9.4 (1.0–15.3)	7.1 (0.6–13.5)	8.6 (0.7–16.7)	6.4 (1.1–15.1)

Data are represented as median (min–max).